Children account for more than 80% of MPOX deaths in the Democratic Republic of Congo, but the first vaccines to arrive in the country will not be given to the youngest and most vulnerable patients.
A new vaccine from the Danish pharmaceutical laboratory Bavarian Nordic A/S The vaccine is expected to arrive in Congo next week, but it is missing from the government’s pediatric vaccination plan, according to public health and humanitarian agencies. Critics say the vaccine should be included.
